These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 22608083)

  • 1. The life history of 21 breast cancers.
    Nik-Zainal S; Van Loo P; Wedge DC; Alexandrov LB; Greenman CD; Lau KW; Raine K; Jones D; Marshall J; Ramakrishna M; Shlien A; Cooke SL; Hinton J; Menzies A; Stebbings LA; Leroy C; Jia M; Rance R; Mudie LJ; Gamble SJ; Stephens PJ; McLaren S; Tarpey PS; Papaemmanuil E; Davies HR; Varela I; McBride DJ; Bignell GR; Leung K; Butler AP; Teague JW; Martin S; Jönsson G; Mariani O; Boyault S; Miron P; Fatima A; Langerød A; Aparicio SA; Tutt A; Sieuwerts AM; Borg Å; Thomas G; Salomon AV; Richardson AL; Børresen-Dale AL; Futreal PA; Stratton MR; Campbell PJ;
    Cell; 2012 May; 149(5):994-1007. PubMed ID: 22608083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combating subclonal evolution of resistant cancer phenotypes.
    Brady SW; McQuerry JA; Qiao Y; Piccolo SR; Shrestha G; Jenkins DF; Layer RM; Pedersen BS; Miller RH; Esch A; Selitsky SR; Parker JS; Anderson LA; Dalley BK; Factor RE; Reddy CB; Boltax JP; Li DY; Moos PJ; Gray JW; Heiser LM; Buys SS; Cohen AL; Johnson WE; Quinlan AR; Marth G; Werner TL; Bild AH
    Nat Commun; 2017 Nov; 8(1):1231. PubMed ID: 29093439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles of Reconstructing the Subclonal Architecture of Cancers.
    Dentro SC; Wedge DC; Van Loo P
    Cold Spring Harb Perspect Med; 2017 Aug; 7(8):. PubMed ID: 28270531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-definition reconstruction of clonal composition in cancer.
    Fischer A; Vázquez-García I; Illingworth CJR; Mustonen V
    Cell Rep; 2014 Jun; 7(5):1740-1752. PubMed ID: 24882004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast tumours maintain a reservoir of subclonal diversity during expansion.
    Minussi DC; Nicholson MD; Ye H; Davis A; Wang K; Baker T; Tarabichi M; Sei E; Du H; Rabbani M; Peng C; Hu M; Bai S; Lin YW; Schalck A; Multani A; Ma J; McDonald TO; Casasent A; Barrera A; Chen H; Lim B; Arun B; Meric-Bernstam F; Van Loo P; Michor F; Navin NE
    Nature; 2021 Apr; 592(7853):302-308. PubMed ID: 33762732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexisting genomic aberrations associated with lymph node metastasis in breast cancer.
    Bao L; Qian Z; Lyng MB; Wang L; Yu Y; Wang T; Zhang X; Yang H; Brünner N; Wang J; Ditzel HJ
    J Clin Invest; 2018 Jun; 128(6):2310-2324. PubMed ID: 29558370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clonal and mutational evolution spectrum of primary triple-negative breast cancers.
    Shah SP; Roth A; Goya R; Oloumi A; Ha G; Zhao Y; Turashvili G; Ding J; Tse K; Haffari G; Bashashati A; Prentice LM; Khattra J; Burleigh A; Yap D; Bernard V; McPherson A; Shumansky K; Crisan A; Giuliany R; Heravi-Moussavi A; Rosner J; Lai D; Birol I; Varhol R; Tam A; Dhalla N; Zeng T; Ma K; Chan SK; Griffith M; Moradian A; Cheng SW; Morin GB; Watson P; Gelmon K; Chia S; Chin SF; Curtis C; Rueda OM; Pharoah PD; Damaraju S; Mackey J; Hoon K; Harkins T; Tadigotla V; Sigaroudinia M; Gascard P; Tlsty T; Costello JF; Meyer IM; Eaves CJ; Wasserman WW; Jones S; Huntsman D; Hirst M; Caldas C; Marra MA; Aparicio S
    Nature; 2012 Apr; 486(7403):395-9. PubMed ID: 22495314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer heterogeneity: converting a limitation into a source of biologic information.
    Rübben A; Araujo A
    J Transl Med; 2017 Sep; 15(1):190. PubMed ID: 28886708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Order Matters: The Order of Somatic Mutations Influences Cancer Evolution.
    Kent DG; Green AR
    Cold Spring Harb Perspect Med; 2017 Apr; 7(4):. PubMed ID: 28096247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring Clonal Evolution in Cancer with Genomics.
    Williams MJ; Sottoriva A; Graham TA
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():309-329. PubMed ID: 31059289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revealing clonality and subclonality of driver genes for clinical survival benefits in breast cancer.
    Lan Y; Zhao E; Luo S; Xiao Y; Li X; Cheng S
    Breast Cancer Res Treat; 2019 May; 175(1):91-104. PubMed ID: 30739230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spatial genomics maps the structure, nature and evolution of cancer clones.
    Lomakin A; Svedlund J; Strell C; Gataric M; Shmatko A; Rukhovich G; Park JS; Ju YS; Dentro S; Kleshchevnikov V; Vaskivskyi V; Li T; Bayraktar OA; Pinder S; Richardson AL; Santagata S; Campbell PJ; Russnes H; Gerstung M; Nilsson M; Yates LR
    Nature; 2022 Nov; 611(7936):594-602. PubMed ID: 36352222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic evolution and global expansion of an ancient transmissible cancer lineage.
    Baez-Ortega A; Gori K; Strakova A; Allen JL; Allum KM; Bansse-Issa L; Bhutia TN; Bisson JL; Briceño C; Castillo Domracheva A; Corrigan AM; Cran HR; Crawford JT; Davis E; de Castro KF; B de Nardi A; de Vos AP; Delgadillo Keenan L; Donelan EM; Espinoza Huerta AR; Faramade IA; Fazil M; Fotopoulou E; Fruean SN; Gallardo-Arrieta F; Glebova O; Gouletsou PG; Häfelin Manrique RF; Henriques JJGP; Horta RS; Ignatenko N; Kane Y; King C; Koenig D; Krupa A; Kruzeniski SJ; Kwon YM; Lanza-Perea M; Lazyan M; Lopez Quintana AM; Losfelt T; Marino G; Martínez Castañeda S; Martínez-López MF; Meyer M; Migneco EJ; Nakanwagi B; Neal KB; Neunzig W; Ní Leathlobhair M; Nixon SJ; Ortega-Pacheco A; Pedraza-Ordoñez F; Peleteiro MC; Polak K; Pye RJ; Reece JF; Rojas Gutierrez J; Sadia H; Schmeling SK; Shamanova O; Sherlock AG; Stammnitz M; Steenland-Smit AE; Svitich A; Tapia Martínez LJ; Thoya Ngoka I; Torres CG; Tudor EM; van der Wel MG; Viţălaru BA; Vural SA; Walkinton O; Wang J; Wehrle-Martinez AS; Widdowson SAE; Stratton MR; Alexandrov LB; Martincorena I; Murchison EP
    Science; 2019 Aug; 365(6452):. PubMed ID: 31371581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in normal breast tissue and breast tumours.
    Tomlinson IP
    Breast Cancer Res; 2001; 3(5):299-303. PubMed ID: 11597318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SubClonal Hierarchy Inference from Somatic Mutations: Automatic Reconstruction of Cancer Evolutionary Trees from Multi-region Next Generation Sequencing.
    Niknafs N; Beleva-Guthrie V; Naiman DQ; Karchin R
    PLoS Comput Biol; 2015 Oct; 11(10):e1004416. PubMed ID: 26436540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclonal diversification of primary breast cancer revealed by multiregion sequencing.
    Yates LR; Gerstung M; Knappskog S; Desmedt C; Gundem G; Van Loo P; Aas T; Alexandrov LB; Larsimont D; Davies H; Li Y; Ju YS; Ramakrishna M; Haugland HK; Lilleng PK; Nik-Zainal S; McLaren S; Butler A; Martin S; Glodzik D; Menzies A; Raine K; Hinton J; Jones D; Mudie LJ; Jiang B; Vincent D; Greene-Colozzi A; Adnet PY; Fatima A; Maetens M; Ignatiadis M; Stratton MR; Sotiriou C; Richardson AL; Lønning PE; Wedge DC; Campbell PJ
    Nat Med; 2015 Jul; 21(7):751-9. PubMed ID: 26099045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 18. The stepwise evolution of the exome during acquisition of docetaxel resistance in breast cancer cells.
    Hansen SN; Ehlers NS; Zhu S; Thomsen MB; Nielsen RL; Liu D; Wang G; Hou Y; Zhang X; Xu X; Bolund L; Yang H; Wang J; Moreira J; Ditzel HJ; Brünner N; Schrohl AS; Stenvang J; Gupta R
    BMC Genomics; 2016 Jun; 17():442. PubMed ID: 27277198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the number of rate limiting genomic changes for human breast cancer.
    Zhang X; Simon R
    Breast Cancer Res Treat; 2005 May; 91(2):121-4. PubMed ID: 15868439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative monitoring of BCR/ABL1 mutants for surveillance of subclone-evolution, -expansion, and -depletion in chronic myeloid leukaemia.
    Preuner S; Mitterbauer G; Mannhalter C; Herndlhofer S; Sperr WR; Valent P; Lion T
    Eur J Cancer; 2012 Jan; 48(2):233-6. PubMed ID: 21955823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.